Way undervalued. It should be trading at 3-4x current year revenue IMO. It's trading at about 1.5x ($18m market cap with our current SP) our current year revenue if we do $10-15m this year.
That's plain ridiculous considering other companies that trade at $50m + market caps I see. Just a matter of time IMO and I expect a gradual climb to around 30-40 cents as next one to two quarters hit. If Novalere deal is announced, we could go to double that fast.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.